CHIeru Co Ltd
OTC:CIERF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CHIeru Co Ltd
OTC:CIERF
|
JP |
|
Filana Therapeutics, Inc
NASDAQ:FLNA
|
US |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
US |
|
C
|
CTX Virtual Technologies Inc
OTC:CTXV
|
US |
|
Soon Lian Holdings Ltd
SGX:5MD
|
SG |
|
E
|
Endurance Gold Corp
OTC:ENDGF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CIERF's stock price target?
Not Available
CIERF doesn't have any price targets made by Wall Street professionals.
What is CHIeru Co Ltd's Revenue forecast?
Projected CAGR
-11%
For the last 10 years the
compound annual growth rate for
CHIeru Co Ltd's revenue is
16%.
The projected
CAGR
for the next 4 years is
-11%.
What is CHIeru Co Ltd's Net Income forecast?
Projected CAGR
-3%
For the last 10 years the
compound annual growth rate for
CHIeru Co Ltd's net income is
17%.
The projected
CAGR
for the next 4 years is
-3%.